Reduces agitation and supports engagement in dementia care
30+ peer-reviewed studies; FDA Class II classification
- Control mode
- Autonomous
- Human intervention
- Facilitated by care staff
By PARO Robots (Intelligent System Co.) · Japan · announced November 2001
The therapeutic baby seal with two decades of peer-reviewed evidence and an FDA medical-device classification.
Use the curated dossier for claim-level citations, regional offers, ownership context, and the current editorial assessment.
Paro is a robotic harp seal pup developed by Takanori Shibata at Japan's AIST, in continuous production since the mid-2000s and in clinical use worldwide. It responds to touch, voice and light with movement and seal sounds, and is used in dementia care to reduce agitation and support engagement, filling the role of animal therapy where live animals are impractical.
It is the most-studied companion robot ever made, with more than 30 peer-reviewed studies, and was classified as a Class II medical device by the US FDA in 2009. A unit costs around $6,100, with leasing around $169 per month through distributors; the eighth-generation design changed little because it did not need to.
Paro chose a seal deliberately: unfamiliar enough that users hold no expectations a robot would fail to meet. Twenty years later, the entire companion-robot industry is still relearning that lesson.
Thousands of units in care facilities worldwide since the 2000s
2 material claims are separated by evidence setting and human involvement. The strongest recorded signal is Commercially deployed; it does not automatically transfer to every row.
30+ peer-reviewed studies; FDA Class II classification
AIST research prototypes
Commercial sales begin in Japan
US FDA Class II classification; international clinical adoption
These sources support the research record as a whole. Unlike the curated dossiers, this imported record does not yet map every claim to a stable source ID.